Henry Schein Inc (HSIC) |
|
62.57 1.07 (1.74%)
|
03-07 04:28 |
|
Open: |
62.36 |
Pre. Close: |
61.5 |
|
High:
|
62.99 |
Low:
|
60.71 |
|
Volume:
|
1,024,545 |
Market Cap:
|
8,914M |
|
|
|
|
Henry Schein, Inc., a solutions company for health care professionals, provides health care products and services to office-based dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates in two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products comprising branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners. This segment also provides value-added practice solutions, which comprise financial services on a non-recourse basis, e-services, practice technology, network, and hardware services, as well as continuing education services for practitioners. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
63.02 - 63.4 |
63.4 - 63.765 |
|
Low:
|
59.825 - 60.266 |
60.266 - 60.688 |
|
Close:
|
61.882 - 62.543 |
62.543 - 63.177 |
|
Technical analysis |
as of: 2021-03-05 5:09:05 PM |
|
Overall:
|
  |
| Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected. |
| Target: |
Six months: 78.89  One year: 83.83 |
| Support: |
Support1: 60.71 Support2: 50.51 |
| Resistance: |
Resistance1: 67.55 Resistance2: 71.77 |
| Pivot: |
64.52 |
| Moving Average: |
MA(5): 62.85 MA(20): 65.99
MA(100): 66.34 MA(250): 62.00 |
| MACD: |
MACD(12,26): -1.73 Signal(9): -1.38 |
| Stochastic oscillator: |
%K(14,3): 12.28 %D(3): 14.31 |
| RSI: |
RSI(14): 39.84 |
| 52-week: |
High: 74.89 Low: 41.85 Change(%): 14.8 |
| Average Vol(K): |
3-Month: 95659 10-Days: 151586 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.HSIC has closed above bottom band by 30.9%. Bollinger Bands are 22% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Sat, 06 Mar 2021
$2.84 Billion in Sales Expected for Henry Schein, Inc. (NASDAQ:HSIC) This Quarter - MarketBeat
Tue, 02 Mar 2021
Henry Schein Inc. (HSIC) Dips 2.53% for March 02 - Equities.com
Mon, 01 Mar 2021
First Week of July 16th Options Trading For Henry Schein (HSIC) - Nasdaq
Tue, 23 Feb 2021
Ethisphere Announces Henry Schein, Inc. as One of the 2021 World's Most Ethical Companies for the 10th Time - Valdosta Daily Times
Sat, 20 Feb 2021
Insider Buying: Mohamad Ali Just Spent US$64k On Henry Schein, Inc. (NASDAQ:HSIC) Shares - Simply Wall St
Wed, 17 Feb 2021
Henry Schein Inc. stock falls Wednesday, underperforms market - MarketWatch
|
Financial Analysis |
| Growth |
|
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
|
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
 |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Price to Book Value: |
Outperform |
Discounted cash flow: |
Outperform |
| Return on Assets: |
Neutral |
Price to Earnings: |
Outperform |
| Return on Equity: |
Neutral |
Debt to Equity: |
Outperform |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Medical Distribution |
| Shares Out. (M) |
143 |
| Shares Float (M) |
141 |
|
% Held by Insiders
|
1.37 |
|
% Held by Institutions
|
98.12 |
|
Shares Short (K)
|
5,150 |
|
Shares Short P. Month (K)
|
5,260 |
Stock Financials |
|
EPS
|
4.090 |
|
EPS Est This Year
|
3.640 |
|
EPS Est Next Year
|
4.010 |
|
Book Value (p.s.)
|
22.150 |
|
Profit Margin
|
6.14 |
|
Operating Margin
|
6.00 |
|
Return on Assets (ttm)
|
4.8 |
|
Return on Equity (ttm)
|
15.6 |
|
Qtrly Rev. Growth
|
13.2 |
|
Gross Profit (p.s.)
|
21.643 |
|
Sales Per Share
|
67.381 |
|
EBITDA (p.s.)
|
5.369 |
|
Qtrly Earnings Growth
|
0.80 |
|
Operating Cash Flow (M)
|
542 |
|
Levered Free Cash Flow (M)
|
470 |
Stock Valuations |
|
PE Ratio
|
15.30 |
|
PEG Ratio
|
|
|
Price to Book value
|
2.82 |
|
Price to Sales
|
0.93 |
|
Price to Cash Flow
|
16.49 |
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
